Internalization of DMSA-Coated Fe3O4 Magnetic Nanoparticles into Mouse Macrophage Cells


Article Preview

This study observed the internalization of Fe3O4 magnetic nanoparticles (MNPs) coated with meso-2, -3-dimercaptosuccinnic acid (DMSA) into mouse macrophage RAW264.7 by using transmission electron microscopy (TEM) and Prussian blue staining. The results showed that the DMSA-coated Fe3O4 MNPs could be efficiently internalized into RAW264.7 cells. The internalized DMSA-coated Fe3O4 MNPs located in the cytoplasmic inclusions. The internalization of DMSA-coated Fe3O4 MNPs did not significantly affect the cell viability at given doses (20, 30, 40, 50 and 100 μg/mL) and incubation times (2, 12, 24, 48 and 72 hours), suggesting DMSA-coated Fe3O4 MNPs had better biocompatibility. This study demonstrated that DMSA-coated Fe3O4 MNPs may provide a potential nanomaterial for biomedical applications.



Advanced Materials Research (Volumes 455-456)

Edited by:

Khine Soe Thaung




Y. X. Liu et al., "Internalization of DMSA-Coated Fe3O4 Magnetic Nanoparticles into Mouse Macrophage Cells", Advanced Materials Research, Vols. 455-456, pp. 1221-1227, 2012

Online since:

January 2012




[1] Salata, Applications of nanoparticles in biology and medicine, J Nanobiotechnology, vol. 2, no. 1, p.3, April (2004).

[2] X. Montet, K. Montet-Abou and F. Reynolds, Nanoparticle imaging of integrins on tumor cells, Neoplasia, vol. 8, no. 3, pp.214-222, March (2006).


[3] L. Tiefenauer, Magnetic nanoparticles as contrast agents for medical diagnosis, Nanotechnology in Biology and Medicine: Methods, Devices, and Applications. Boca Raton, CRC Press, Taylor & Francis Group LLC, no. pp.29-21, (2007).


[4] G. Morana, E. Salviato, and A. Guarise, Contrast agents for hepatic MRI, Cancer Imaging, vol. 7, Spec issue A, pp. S24-27, October (2007).

[5] H. Nam, S. Kwon, and H. Chung, Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles, J Control Release, vol. 135, no. 3, pp.259-267, May (2009).


[6] C. Wilhelm, F. Gazeau, and J. Roger, Interaction of anionic superparamagnetic nanoparticles with cells: Kinetic analyses of membrane adsorption and subsequent internalization, Langmuir, vol. 18, no. 21, pp.8148-8155, October (2002).


[7] C. Wilhelm, C. Billotey, and J. Roger, Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating, Biomaterials, vol. 24, no. 6, pp.1001-1011, March (2003).


[8] C. Wilhelm, and F. Gazeau, Universal cell labelling with anionic magnetic nanoparticles, Biomaterials, vol. 29, no. 22, pp.3161-3174, August (2008).


[9] J. Zhou, C. Leuschner, and C. Kumar, A tem study of functionalized magnetic nanoparticles targeting breast cancer cells, Mat Sci Eng C-Bio S, vol. 26, no. 8, pp.1451-1455, September (2006).


[10] C. Riviere, F. Boudghene, and F. Gazeau, Iron oxide nanoparticle-labeled rat smooth muscle cells: Cardiac mr imaging for cell graft monitoring and quantitation, Radiology, vol. 235, no. 3, pp.959-967, June (2005).


[11] S. Zhang, X. Chen, and C. Gu, The effect of iron oxide magnetic nanoparticles on smooth muscle cells, Nanoscale Res Lett, vol. 4, no. 1, pp.70-77, Januay (2009).

[12] N. Kohler, C. Sun, and J. Wang, Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells, Langmuir, vol. 21, no. 19, pp.8858-8864, September (2005).


[13] Y. Zhang and J. Zhang, Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells, J Colloid Interf Sci, vol. 283, no. 2, pp.352-357, March (2005).


[14] Y. Ge, Y. Zhang, and S. He, Fluorescence modified chitosan-coated magnetic nanoparticles for high-efficient cellular imaging, Nanoscale research letters, vol. 4, no. 4, pp.287-295, January (2009).


[15] Z. P. Chen, Y. Zhang, and S. Zhang, Preparation and characterization of water-soluble monodisperse magnetic iron oxide nanoparticles via surface double-exchange with dmsa, Colloid Surface A, vol. 316, no. 1-3, pp.210-216, March (2008).


[16] S. Schwarz, F. Fernandes, and L. Sanroman, Synthetic and biogenic magnetite nanoparticles for tracking of stem cells and dendritic cells, J Magn Magn Mater, vol. 321, no. 10, pp.1533-1538, May (2009).


[17] C. Becker, M. Hodenius, and G. Blendinger, Uptake of magnetic nanoparticles into cells for cell tracking, J Magn Magn Mater, vol. 311, no. 1, pp.234-237, April (2007).

[18] G. Goya, I. Marcos-Campos, R. Fernández-Pacheco, Dendritic cell uptake of iron-based magnetic nanoparticles, Cell Biol Int, vol. 32, no. 8, pp.1001-1005, August (2008).

[19] U. Hafelli, J. Riffle, and L. Harris-Shekhawat, Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery, Mol Pharmaceut, vol. 6, no. 5, pp.1417-1428, Sep-Oct (2009).

[20] M. Auffan, L. Decome, and J. Rose, In vitro interactions between dmsa-coated maghemite nanoparticles and human fibroblasts: A physicochemical and cyto-genotoxical study, Environ Sci Technol, vol. 40, no. 14, pp.4367-4373, July (2006).


[21] J. Zhou, C. Leuschner, and C. Kumar, Sub-cellular accumulation of magnetic nanoparticles in breast tumors and metastases, Biomaterials, vol. 27, no. 9, pp.2001-2008, March (2006).


[22] K. Wagner, A. Kautz, and M. Roder, Synthesis of oligonucleotide-functionalized magnetic nanoparticles and study on their in vitro cell uptake, Appl Organomet Chem, vol. 18, no. 10, pp.514-519, October (2004).


[23] J. G. Xia, S. Zhang, and Y. Zhang, The relationship between internalization of magnetic nanoparticles and changes of cellular optical scatter signal, J Nanosci Nanotechno, vol. 8, no. 12, pp.6310-6315, December (2008).


[24] V. H. B. Ho, A. Barcza, and R. Chen, The precise control of cell labelling with streptavidin paramagnetic particles, Biomaterials, vol. 30, no. 33, pp.6548-6555, November (2009).


[25] B. Bacon, D. Stark, and C. Park, Ferrite particles: A new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration, J Lab Clin Med, vol. 110, no. 2, pp.164-171, August (1987).

[26] R. Weissleder, D. Stark, and B. Engelstad, Superparamagnetic iron-oxide: Pharmacokinetics and toxicity, Am J Roentgenol, vol. 152, no. 1, pp.167-173, January (1989).